LayerBio CEO Presents OcuRing-K at OIS Anterior Innovation Showcase
Apr. 8, 2021
Courtesy ofLayerBio, Inc
Dr. Ken Mandell, Founder and CEO of LayerBio, presented an update on the development of its novel OcuRing-K ketorolac implant for treatment of postoperative pain and inflammation with cataract surgery.
Stay in the loop!
Select your areas of interest to receive industry updates.